跳至主要内容
临床试验/NCT01568723
NCT01568723已完成不适用

Stem Cells And The Origins Of Barrett's Esophagus:Identification Of Novel Biomarkers And Gene Signatures In Barrett's Esophagus

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
125
试验地点
2
主要终点
Response to therapy

研究概览

简要总结

The purpose of this study is to determine biomarkers which can predict response to ablation therapy in patients with Barretts esophagus.

详细描述

This Project is designed to identify biologically-based and clinically-useful biomarkers of tissue at risk for neoplastic progression as well as of response to ablation therapy. These results will result in improved risk stratification in BE and better targeting of resources for patients who are candidates for ablative therapy, while simultaneously providing key information regarding the origins of Barrett's esophagus.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Barrett's esophagus with high grade dysplasia or intramucosal (early) adenocarcinoma.
  • BE length ≥ 2 cm and ≤ 8 cm.
  • Able to return every 3 months for one year after ablation

排除标准

  • Patients who are unable to be compliant with follow-up endoscopies
  • patients who cannot tolerate Proton Pump inhibitors
  • pre-existing esophageal strictures
  • pregnant or nursing women

结局指标

主要结局

Response to therapy

时间窗: one year post ablation

evaulation will be made at 3 month intervals for one year post ablation

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kenneth K. Wang

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验